Crossmark

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma

Crossref DOI link: https://doi.org/10.1245/s10434-018-6435-4

Published Online: 2018-03-22

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Goense, Lucas

van Rossum, Peter S. N.

Xi, Mian

Maru, Dipen M.

Carter, Brett W.

Meijer, Gert J.

Ho, Linus

van Hillegersberg, Richard

Hofstetter, Wayne L.

Lin, Steven H.
License Information

Text and Data Mining valid from 2018-03-22
More Information

Article History

Received: 18 December 2017

First Online: 22 March 2018